Evidence map›Paper›PMID 38695132›Full record

ArticleHaematologica2024

Soluble urokinase plasminogen activator receptor is associated with kidney disease and its progression in sickle cell anemia.

Rima S Zahr, Sara R Rashkin, Maria Armila Ruiz, Laila Elsherif, Guohui Ren, Guadalupe Salas, Kenneth I Ataga, Victor R Gordeuk, Jeffrey Lebensburger, Xu Zhang and 1 more

Open access · goldAbstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Haematologica, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 90% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Rima S ZahrDivision of Pediatric Nephrology and Hypertension, University of Tennessee Health Science Center Memphis, TN. rzahr@uthsc.edu.
Sara R RashkinDepartment of Hematology, St. Jude Children's Research Hospital, Memphis, TN.
Maria Armila RuizDivision of Hematology and Oncology, University of Illinois at Chicago, Chicago, IL.
Laila ElsherifCenter for Sickle Cell Disease, University of Tennessee Health Sciences Center, Memphis, TN.
Guohui RenDivision of Hematology and Oncology, University of Illinois at Chicago, Chicago, IL.
Guadalupe SalasDivision of Hematology and Oncology, University of Illinois at Chicago, Chicago, IL.
Kenneth I AtagaCenter for Sickle Cell Disease, University of Tennessee Health Sciences Center, Memphis, TN.
Victor R GordeukDivision of Hematology and Oncology, University of Illinois at Chicago, Chicago, IL.
Jeffrey LebensburgerDivision of Pediatric Hematology and Oncology, University of Alabama at Birmingham, Birmingham, AL.
Xu ZhangDivision of Hematology and Oncology, University of Illinois at Chicago, Chicago, IL.
Santosh L SarafDivision of Hematology and Oncology, University of Illinois at Chicago, Chicago, IL. ssaraf@uic.edu.
University of Illinois Chicago · USUniversity of Tennessee Health Science Center · USSt. Jude Children's Research Hospital · USUniversity of Alabama at Birmingham · US

Funding

Pathways of Cell-Free Hemoglobin in Sickle Cell NephropathyR01HL153161 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI SARAF, SANTOSH · 2020 to 2024
$2.0M
Genetic modifiers of Sickle Cell Kidney DiseaseK23HL157554 · NHLBI · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI Rima Zahr · 2022 to 2026
$849k
NHLBI NIH HHS K23 HL157554NHLBI NIH HHS R01 HL153161
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Anemia, Sickle CellDisease ProgressionReceptors, Urokinase Plasminogen ActivatorAdultBiomarkersFemaleHumansKidney DiseasesMaleBiomarkersReceptors, Urokinase Plasminogen Activator

Identifiers

PMID38695132
PMCPMC11443370
OpenAlexW4396585962

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.